JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M405329200 on September 3, 2004

J. Biol. Chem., Vol. 279, Issue 47, 49105-49112, November 19, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/47/49105    most recent
M405329200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ghersi, E.
Right arrow Articles by D'Adamio, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ghersi, E.
Right arrow Articles by D'Adamio, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Amyloid-{beta} Protein Precursor (A{beta}PP) Intracellular Domain-associated Protein-1 Proteins Bind to A{beta}PP and Modulate Its Processing in an Isoform-specific Manner*

Enrico Ghersi{ddagger}, Cristiana Noviello{ddagger}§, and Luciano D'Adamio{ddagger}

From the {ddagger}Department of Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461

The amyloid-{beta} protein precursor (A{beta}PP) is a type I transmembrane molecule that undergoes several finely regulated cleavage events. The physiopathological relevance of A{beta}PP derives from the fact that its aberrant processing strongly correlates with the onset of Alzheimer's disease (AD). AD is a neurodegenerative disorder characterized by neuronal cell death, loss of synapses, and deposition of misfolded protein plaques in the brain; the main constituent of these plaques is the amyloid-{beta} peptide, a 40–42 amino-acid-long protein fragment derived by A{beta}PP upon two sequential processing events. Mutations in the genes encoding for A{beta}PP and some of the enzymes responsible for its processing are strongly associated with familial forms of early onset AD. Therefore, the elucidation of the mechanisms underlying A{beta}PP metabolism appears crucial to understanding the basis for the onset of AD. Apart from A{beta}, upon processing of A{beta}PP other fragments are generated. The long extracellular domain is released in the extracellular space, whereas the short cytoplasmic tail, named A{beta}PP intracellular domain (AID) is released intracellularly. AID appears be involved in several cellular processes, apoptosis, calcium homeostasis, and transcriptional regulation. We have recently reported the cloning and characterization of different isoforms of AID associated protein-1 (AIDA-1), a novel AID-binding protein. Here we further analyzed the interaction between several AIDA-1 isoforms and the cytoplasmic tail of A{beta}PP. Our data demonstrated that the interaction between the two molecules is regulated by alternative splicing of the AIDA-1 proteins. Furthermore, we provide data supporting a possible function for AIDA-1a as a modulator of A{beta}PP processing.


Received for publication, May 12, 2004 , and in revised form, August 23, 2004.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AY620824.

* This work was supported by an Alzheimer's Disease Research Grant A2003-076, National Institutes of Health Grants NIH RO1 AG 22024 and NIH RO1 AG21588 (to L. D.), and by a Telethon Italia grant (to C. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Present address: Dipartimento di Biochimica e Biotecnologie Mediche, Universita' Degli Studi di Napoli Federico II, CEINGE Biotecnologie Avanzate, Via Comunale Margherita 482, 80145 Naples, Italy.

To whom correspondence should be addressed: Albert Einstein College of Medicine, Dept. of Microbiology and Immunology, 1300 Morris Park Ave., Bronx, NY 10461. E-mail: ldadamio{at}aecom.yu.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
J. Shin, C. Gu, E. Park, and S. Park
Identification of Phosphotyrosine Binding Domain-Containing Proteins as Novel Downstream Targets of the EphA8 Signaling Function
Mol. Cell. Biol., December 1, 2007; 27(23): 8113 - 8126.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Sumioka, S. Nagaishi, T. Yoshida, A. Lin, M. Miura, and T. Suzuki
Role of 14-3-3{gamma} in FE65-dependent Gene Transactivation Mediated by the Amyloid {beta}-Protein Precursor Cytoplasmic Fragment
J. Biol. Chem., December 23, 2005; 280(51): 42364 - 42374.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.